Web Scouter
Back to News
Security News

Biocon Announces Supplemental U.S. FDA Approval for Prefilled Autoinjector for YESINTEK

UnknownAug 28, 2026(3 days ago)

Biocon Announces Supplemental U.S. FDA Approval for Prefilled Autoinjector for YESINTEK

On August 18, 2026, Biocon Ltd. (“Biocon”) announced that its U.S. subsidiary has received supplemental U.S. FDA approval for YESINTEK® (ustekinumab-kfce) in a single-dose prefilled autoinjector, 45 mg/0.5 mL and 90 mg/mL. ... By: Goodwin

Related News

SEC charges former executives of subprime auto lender with securities fraud over alleged double-pledging scheme

Unknown19 minutes ago

The Week in Private Credit - August 28, 2026

Unknown20 minutes ago

SBA proposes overhaul of small business size standards

Unknown27 minutes ago

Get Personalized Alerts

Track vendors and receive alerts when security incidents affect your supply chain.

What We Monitor

Security Incidents

Data breaches, ransomware, and unauthorized access

Vulnerabilities

CVEs and vendor security advisories

Compliance Updates

Regulatory changes and certification news

Legal News

Privacy laws and enforcement actions

Vendor Directory

Browse our directory of SaaS vendors with security documentation and compliance information.